| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $99.5M | -5.8% |
| Cost of Revenue | $33.5M | +6.3% |
| Gross Profit | $66.0M | -11.0% |
| R&D Expense | $11.0M | +32.6% |
| SG&A Expense | $49.6M | +8.0% |
| Operating Income | -$34.9M | -136.2% |
| Interest Expense | $4.6M | -8.0% |
| Pre-tax Income | -$44.3M | -93.9% |
| Income Tax | -$722K | -2.1% |
| Net Income | -$43.7M | -89.9% |
| EPS (Basic) | -$0.66 | -57.1% |
| EPS (Diluted) | -$0.66 | -57.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.6M | -62.5% |
| Accounts Receivable | $37.3M | -20.6% |
| Inventory | $23.9M | +16.4% |
| Current Assets | $84.0M | -21.5% |
| Total Assets | $125.4M | -18.5% |
| Current Liabilities | $39.6M | +26.8% |
| Long-term Debt | $70.0M | -9.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.0M | -36.5% |
| Capital Expenditures | $336K | -34.4% |
| Investing Cash Flow | -$336K | +39.1% |
| Financing Cash Flow | $8.0M | -52.4% |
| Free Cash Flow | -$27.3M | -34.7% |
| Total Liabilities |
| $116.6M |
| +3.9% |
| Stockholders' Equity | $8.1M | -80.2% |